newsfilter
← Latest News
Business Wire·

Athersys Appoints Joseph Nolan to Its Board of Directors

Athersys, Inc. (NASDAQ:ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today the appointment of Joseph "Joe" Nolan to its Board of Directors,